Showing 1681-1690 of 3310 results for "".
Pipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigInnovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
https://practicaldermatology.com/programs/cme/innovations-in-oncology-learning-center-from-guidelines-to-practice-melanoma/33212/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Topical Tretinoin: A Versatile Option for Adult Female Acne
https://practicaldermatology.com/issues/supplements/topical-tretinoin-a-versatileoption-for-adult-female-acne/23042/Findings of a roundtable discussion with leading acne experts on the benefits of retinoids for acne patients.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-8/23162/Diversity and Equity in Dermatology
https://practicaldermatology.com/topics/practice-management/diversity-and-equity-in-dermatology/23456/When Topicals Fail: The New IPC Consensus Every Clinician Should Know
https://practicaldermatology.com/programs/cme/when-topicals-fail-the-new-ipc-consensus-every-clinician-should-know/39967/Review IPC’s 2025 consensus guidance on reclassifying psoriasis severity and redefining failure of topical therapies.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-36/23740/Cosmeceuticals: Sunscreens
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-sunscreens/21366/What you should know about the FDA's final ruling on sunscreen products and tips for understanding the variety of sun protection ingredients available to make more informed recommendations to patients.Approvals in Psoriasis and Skin Cancer Highlight a Year of Innovation in Skin Disease Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approvals-in-psoriasis-and-skin-cancer-highlight-a-year-of-innovation-in-skin-disease-management/21069/After periods of low drug approval rates, the last year brought several new agents to market.